Caution noted when that failure was put out. Not a Biotech person myself but in that the drug at TTPH is different then the one CTIX has leans me more toward the open door , or in this situation a bigger open door for CTIX till released info indicates otherwise . Staying a little diversified helps ease any bumps like that for me.